Short and long-term mortality with nesiritide
Authors:
- 1 December 2006
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 152 (6) , 1084-1090
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- TBAJournal of Cardiac Failure, 2005
- Risk of Death With NesiritideJAMA, 2005
- Nesiritide — Not VerifiedNew England Journal of Medicine, 2005
- Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart FailureCirculation, 2005
- Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of CardiologyEuropean Heart Journal, 2005
- Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)The American Journal of Cardiology, 2004
- Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart FailureNew England Journal of Medicine, 2000
- Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failureJACC, 1999
- A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart FailureNew England Journal of Medicine, 1998
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991